Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-17

Clinical Trial Update: The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

View source ↗

Summary

Clinical trial evaluating the benefits of continuing ovarian function suppression beyond five years in women with breast cancer receiving endocrine therapy; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hongmei Zheng, PhD | Conditions: Breast Cancer Female, Endocrine Therapy | Status: RECRUITING